Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $45.23 million. The enterprise value is -$31.71 million.

Market Cap	45.23M
Enterprise Value	-31.71M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.20 million shares outstanding. The number of shares has increased by 11.51% in one year.

Current Share Class	31.20M
Shares Outstanding	31.20M
Shares Change (YoY)	+11.51%
Shares Change (QoQ)	+3.22%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	31.82%
Float	30.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.18
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.04.

Current Ratio	10.25
Quick Ratio	10.14
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.05% and return on invested capital (ROIC) is -65.57%.

Return on Equity (ROE)	-100.05%
Return on Assets (ROA)	-32.85%
Return on Capital (ROIC)	-65.57%
Revenue Per Employee	$1,653
Profits Per Employee	-$835,000
Employee Count	49
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.36% in the last 52 weeks. The beta is 0.15, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-66.36%
50-Day Moving Average	1.74
200-Day Moving Average	5.44
Relative Strength Index (RSI)	36.94
Average Volume (20 Days)	256,804

Short Selling Information

The latest short interest is 1.45 million, so 4.66% of the outstanding shares have been sold short.

Short Interest	1.45M
Short Previous Month	1.97M
Short % of Shares Out	4.66%
Short % of Float	4.79%
Short Ratio (days to cover)	5.72

Income Statement

In the last 12 months, ATNM had revenue of $81,000 and -$40.92 million in losses. Loss per share was -$1.40.

Revenue	81,000
Gross Profit	81,000
Operating Income	-44.96M
Pretax Income	-42.62M
Net Income	-40.92M
EBITDA	-44.73M
EBIT	-44.96M
Loss Per Share	-$1.40

Balance Sheet

The company has $78.66 million in cash and $1.71 million in debt, giving a net cash position of $76.95 million or $2.47 per share.

Cash & Cash Equivalents	78.66M
Total Debt	1.71M
Net Cash	76.95M
Net Cash Per Share	$2.47
Equity (Book Value)	38.21M
Book Value Per Share	1.22
Working Capital	71.77M

Cash Flow

In the last 12 months, operating cash flow was -$34.81 million and capital expenditures -$11,000, giving a free cash flow of -$34.82 million.

Operating Cash Flow	-34.81M
Capital Expenditures	-11,000
Free Cash Flow	-34.82M
FCF Per Share	-$1.12

Margins

Gross Margin	100.00%
Operating Margin	-55,504.94%
Pretax Margin	-50,512.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-41,977.78%

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.51%
Shareholder Yield	-11.51%
Earnings Yield	-90.45%
FCF Yield	-76.98%

Analyst Forecast

The average price target for ATNM is $10.20, which is 603.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.20
Price Target Difference	603.45%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	441.44%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 0.03333333:1.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	0.03333333:1

Scores

ATNM has an Altman Z-Score of -4.73 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.73
Piotroski F-Score	2